- An antihistamine
- A potent long-acting tricyclic antihistamine with selective peripheral H1-receptor antagonistic activity.
- Relief of symptoms associated with allergic rhinitis eg, sneezing, nasal discharge (rhinorrhea) and itching, as well as ocular itching and burning. Nasal and ocular signs and symptoms are relieved rapidly after oral administration.
|Adults and Children ≥ 12 years||1 tablet (10mg)|
|Children 2-12 years ≤ 30 kg||1/2 tablet|
|Children 2-12 years > 30 kg||1 tablet|
|1-2 years||1/4 tablet|
- 10MG Loratadine
- Inactive Ingredients: Corn Starch, Lactose, and Magnesium Stearate
- Patients with severe liver impairment should be administered a lower initial dose because they may have reduced clearance of loratadine; an initial dose of 5 mg or 5 mL once daily, or 10 mg or 10 mL every other day is recommended.
- Safe use of Claritin during pregnancy has not been established; therefore, use only if potential benefit justifies potential risk to fetus.
- Since loratadine is excreted in breast milk and because of the increased risk of antihistamines for infants, particularly newborns and premature infants, a decision should be made whether to discontinue nursing or discontinue the drug.
- Efficacy of Claritin has not yet been established in children <2 years. However, the pharmacokinetic profile of loratadine in infants 1-2 years after the administration of Claritin syrup 2.5 mg as a single dose is similar to that in older children and adults.